ResearcherGuilin Medical UniversityNo recent work listed

Bo Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4089-5155; OpenAlex author ID A5052226142. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper

Papers 2

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. Co-author DOI 10.1038/srep13563 ↗
Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activ… Co-author DOI 10.1007/s12032-012-0175-2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Songqing He · 1 shared paper, 2015 · strength 0.05
- Paper Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. DOI 10.1038/srep13563 ↗
Zhongyu Wang · 1 shared paper, 2012 · strength 0.03
- Paper Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned… DOI 10.1007/s12032-012-0175-2 ↗
Guang Tan · 1 shared paper, 2012 · strength 0.03
- Paper Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned… DOI 10.1007/s12032-012-0175-2 ↗
Jian Du · 1 shared paper, 2012 · strength 0.03
- Paper Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned… DOI 10.1007/s12032-012-0175-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.